Teladoc (TDOC) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.37 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4.26%. A quarter ago, it was expected that this telehealth services provider would post a loss of $0.22 per share when it actually produced a loss of $0.17, delivering a surprise of 22.73%.Over the last four quarters, the company ...

Cautionary Note • This presentation may include certain non-GAAP financial measures as defined by SEC rules. Teladoc Health believes that the presentation of such non-GAAP financial measures enhances an investor's understanding of the Company's financial performance. Teladoc Health uses certain non-GAAP financial measures for business planning purposes and in measuring the Company's performance relative to that of its competitors. For additional information regarding these non-GAAP financial measures, inclu ...

"We are pleased to report a solid start to the year, with strength in both revenue and adjusted EBITDA in the first quarter," said Mala Murthy, acting chief executive officer and chief financial officer of Teladoc Health. "During this period of transition, our team remains laser focused on our key initiatives, which include building upon our market leadership position; driving increased product penetration through our large installed base of over 90 million virtual care members; and accelerating our bottom- ...

Teladoc Health, Inc. (TDOC) is set to report its first-quarter 2024 results on Apr 25, after the closing bell. Analysts anticipate a robust performance in the Integrated Care segment, although rising costs may partially offset its results. Let’s delve deeper.Factors Impacting TDOCTeladoc’s top line has been benefiting on the back of higher Access Fees, visits and segmental growth in Integrated Care. Growth in U.S. Integrated Care members is likely to have fueled growth in its first-quarter results. Our esti ...

Has the telehealth provider entered value territory?Investor sentiment surrounding Teladoc (TDOC -1.20%) has been bad for a while now. The telemedicine specialist's stock is down 95% from its all-time high in 2021.Teladoc's business boomed during the early days of the COVID-19 pandemic, benefiting enormously by providing at-home virtual care to patients. But like so many of the other "stay-at-home" stocks, Teladoc has struggled mightily since life returned to normal. The company is not currently profitable, ...

PURCHASE, NY, April 12, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2024 results on Thursday, April 25, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For international ...

One of the top-performing stocks of 2020 and 2021 is near an eight-year low.Shares of Teladoc Health (TDOC 1.68%) have plummeted from the high-water mark they set during the COVID-19 pandemic emergency. The stock is down about 95% from the peak it set a few years ago, and its board of directors finally did something about it.On April 5, Teladoc's board of directors told investors that its CEO since 2009, Jason Gorevic, is departing immediately. The announcement contains no quotes from Gorevic, and the board ...

Today's CEO switcheroo could hand investors a buying opportunity.Shares of virtual healthcare provider Teladoc Health (TDOC 1.05%) tumbled nearly 5% in early trading Friday before turning around and climbing back into the green. The company announced this morning that CEO Jason Gorevic is departing the company "effective immediately," to be replaced by current CFO Mala Murthy as acting CEO.As of 11:10 a.m. ET, Teladoc shares are up about 0.2%.Teladoc's CEO has left the buildingTeladoc gave no clear explanat ...

Teladoc Health (NYSE:TDOC) stock is a hot topic on Friday as investors react to news of CEO Jason Gorevic stepping down.Taking over for Gorevice is Chief Financial Officer Mala Murthy. This will only be temporary as the company searches for a permanent replacement for Gorevice. It will consider both internal and external candidates.What’s interesting about this is Gorevice has been leading Teladoc since 2019. This put him in control of the company throughout the Covid-19 pandemic.Demand for virtual doctor v ...

Teladoc Health on Friday announced the sudden departure of CEO Jason Gorevic, who is leaving his role as head of the company effective immediately, according to a release.The company's board of directors has temporarily appointed CFO Mala Murthy as Gorevic's replacement and hired an executive search firm to determine a permanent successor.Shares of Teladoc were mostly flat in premarket trading Friday but are down about 34% year-to-date. The stock has also fallen from a high of $294.54 in February 2021 to ab ...